Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Therapy Name||DST-2970 + Prednisone|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|DST-2970||DST2970|DST 2970||Hormone - Anti-androgens 32||DST-2970 is a solid dispersion formulation of abiraterone, which inhibits the cytochrome p450 family enzyme Cyp17a1 potentially leading to inhibition of testosterone production (NCI Drug Dictionary).|
|Prednisone||Adasone||Dehydrocortisone||Adasone (prednisone) is a corticosteroid which functions as an immunosuppressant and anti-inflammatory agent and which may stimulate apoptosis in tumor cells (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04291664||Phase I||Abiraterone + Prednisone DST-2970 + Prednisone||PK and Dose Escalation and Expansion Study of DST-2970||Recruiting||USA||0|